Categories
Uncategorized

Who’s Really Innovative?

This WSJ article http://blogs.wsj.com/management/2010/11/22/whos-really-innovative/ looks at two lists of the world’s most innovative companies – one by Fast Company and the other by BusinessWeek – and attempts to define what it means to be innovative. I found the author’s taxonomy for distinguishing innovative companies to be very interesting. He writes about five distinct kinds of innovators. First, the tyros. These are young companies built on wacky business models that haven’t been challenged to reinvent yet. Hulu and spotify fall in this category. Next are the Nobel laureates. These are technology companies like Intel, Samsung, Novartis and Cisco that spend billions on R&D each year and hire the smartest engineers and scientists. The third and a much smaller category of innovation heroes are the Artistes. These firms are in the creativity business and their main product is innovation. IDEO and BMW DesignWorks fit this category. Next are the Cyborgs, companies like Google, Apple and Amazon that consistently achieve super human feats of innovation. The fifth kind are the Born again innovators which the author considers the most notable. These are companies like P&G, IBM and Ford which after years of top-down, hierarchical and orthodox practices have reassessed and reinvented their behavior. IBM’s EBO process is one notable example.

Categories
Uncategorized

Collaboration Required in Pharmaceutical Industry

Pharmaceutical industry is in a state of crisis. That’s the message Ted Torphy, VP from Johnson & Johnson, sent to us in his Berkeley talk.  The reason? A lack of innovation, not in terms of technological ones in R&D, rather, R&D business models innovations.

Developing a new drug is a lengthy and costly process, averaging 11 years and $1bn. And, in addition to big Pharmaceuticals, it involves participations of multiple entities including Academia, Venture Capitals (VCs), Government, and Public Markets. Following graph lists the traditional drug development lifecycle along with its participants (ranked by their contributions) at various stages.

DrugDevProcess

(Just for explanation purposes, Phase I is to test the safety of the drug. Phase II is divided into two sub phases where II a tests if the drug works for the targeted population and II b is to identify the right dose of the drug. And Phase III deals with large scale clinical testing.)

Research suggested that out of $1bn R&D investment, 35-40% went to stages before Phase II b (early-stage development), and the most importantly, success rate jumped up from 1.5% at “Innovation” to 50% when it came to Phase II b. So, in the pharmaceutical world, the stage right before Phase II b is called “Clinical Proof of Concept”, and they want to bring drugs to pass that stage more rapid and economical. To do that, they started to acquire new biotech companies that already have some success in early-stage development instead of investing tremendous resources in their own R&D. This mindset results in the fact that biotech organizations are becoming the source of new products. However, risky nature of this early-stage development together with the requirement of a big lump-sum up-front investment usually turns away interested VCs, which causes an investment gap between basic research and late-stage drug development.

What is the proposed solution? Dr. Torphy recommended “Virtual Integration”. Contrary to “Vertical Integration”, where firms gain top-down controls for everything and “Vertical Disintegration”, where companies outsource to others services/products that are not in line with their core businesses, “Virtual Integration” encourages collaborations or alliances among businesses to share competencies, infrastructure, intellectual capital, risk and rewards.

He argues that this is beneficial to all the stakeholders in the ecosystem. For example, large pharmaceuticals can benefit by expanding pipelines with an external portfolio of product opportunities, minimizing fixed costs and infrastructure while maximizing flexibility. VCs can reduce their capital investments by gaining access to pharmaceuticals’ infrastructure and expertise. Academia, on the other hand, will have the ability to tap into external funding resources.

“Virtual Integration”, in a sense, is Open Innovation, embracing the expertise and resources from partners, suppliers, R&D institutions, etc. But as Dr. Torphy suggested, it is not easy to sell the concept. It requires all the participants to share the same collaboration mindset, to overcome the “Not-Invented-Here” barrier and to create a fluid system to exchange ideas, expertise and resources.

Categories
Uncategorized

FIAT – Innovation in a Downturn

Innovation, in a traditional sense, will happen only with the corporate sponsorship both financially and strategically. When companies are facing economic downturns, it is no surprise that R&D department is usually the first facing budget-cut and thus it would have to scale down, causing innovation either halted, or at least slowed down to a certain extent. Alberto Di Minin from Sant’Anna School of Advanced Studies was giving a talk at Berkeley recently in “Open Innovation” class, presenting a really good counter-intuitive case where Fiat, the Italian auto giant, succeeded in securing the financial future through open innovation even during a downturn.

Quoting from President Obama: “the international company Fiat is the only route to survival for Chrysler”, he directly pointed out that, without the fruitful R&D in the past decade, Fiat could not possibly be in the place where it is today. In 1994, Fiat was facing a huge downturn; whereas it had to cut back on funding in corporate R&D (Fiat Research Center or CRF) almost 70%. However, CRF was not dead, and instead, it boomed and doubled its revenue in 2004. Why? The secret sauce was that CRF took the initiative to go out and gain access to external resources.

Strategy-wise, with the acknowledgement from corporate headquarters, CRF changed its mission to provide ‘competitiveness’ to its customers, which implied that CRF was then selling not only technology, but also the services plus the human capital that could come along with the technology.

First, a matrix structure was developed to find the right match between the technology and the client profile. Then, its next goal was to identify the “right” customers, develop the client relation and turn them into long term partners, which usually translates to “more trust” and “more profits”. With such good partner relations, CRF could be able to start transferring knowledge, or even people which usually come around technology transfer. This required a HR-oriented culture where competences and high turnovers were encouraged. With these former CRF employees disseminated into other partner organizations, they became the CRF advocates who would in turn bring in more businesses. This was a great ecosystem where both CRF and its customers were mutually beneficial.

Although the system was great, Fiat wasn’t perfect in running the system. Fiat did make a mistake by having the Intellectual Property (IP) exclusively owned by the headquarter who wasn’t aware of the potential impact of some core technology. This caused billions in potential revenue loss, although Fiat corrected the mistake later by changing the policy that CRF would have the right to own IPs.

Alberto explained in much detail about the ‘competitiveness’ selling model. He compared the model to the one preparing dinner for friends. Sometimes, clients might not know what they want, or even they know they want, CRF simply doesn’t know how to price it. This is like having ingredients in your shopping list, but you don’t know how to make the food. In order to make the food, you will have to know the features of the ingredients. Likewise, CRF would have to know more about clients before they could make a technology transfer. In this case, bottom-up planning was required, and researchers would have to carry multiple hats as project managers and marketers to make the technology transfer happen. But when food is prepared, maybe your friends are not satisfied, and they possibly want more: wine, sides, etc. The same case for clients, they might be willing to pay CRF to integrate CRF’s technology with their own system. Or even better, they might be interested in collaborating with CRF for future projects. Both open up an entirely new business space for CRF.

In this particular story about Fiat, the shortness in budget and the dismal future of the CRF raised red alerts for both corporate leaders and regular employees. This “tough-time” mentality enabled them to be more proactive: they are more concerned about the operational efficiency and R&D effectiveness; they are more willing to take initiatives going out and hunting for external resources. That’s exactly a good environment for innovation. But does this only happen during the downturn? Could the leaders be as tough and determined as they could be in the downturn? Could the corporate culture shift as smoothly and swiftly as it could in the downturn from a closed innovation mentality to an open innovation one?

Categories
Uncategorized

Beyond the electric car, a Better Place

Ipod has dominated the MP3 market because Apple went beyond the hardware and created an ecosystem where people could conveniently buy music legally online.  Then Apple topped itself with the iPhone and the App Store.  Similarly, Better Place promotes the adoption of electric vehicles (EVs) by building and operating the infrastructure and network systems to optimize energy access and use.  Instead of asking consumers to pay a premium for the EVs with the battery, a consumer can buy a EV and lease the battery separately.  Battery switching stations are provided for customers to swap out the low charge battery with a fully charged one.  Thus battery technology upgrade will be no cost to the EVs’ owners and the travel range is no longer an issue.  Israel and Denmark have already signed up.

Hopefully, this innovation will dispel the fears of consumers against the adoption of EVs.

http://www.betterplace.com/

Categories
Uncategorized

Exerting the influence

In the Sep 17th class, we discussed how to spread influence around by managing up, down and across organizations. We also studied the influence tactics of being a good innovation managers. Walter raised a good question in class asking if we could actually learn to acquire those tactics.

Here is an interview of Marshall Goldsmith, who generally trains leaders to act differently and he also talks about some basic rules of managing up.

– It’s our responsibility to sell the ideas, not upper management’s obligations to buy.

– Focus on contribution to the larger good — not just the achievement of our objectives. (this is mentioned in class, where we talked about understanding others’ – decision makers’ or even opponents’ – concerns.

– Present a realistic cost-benefit analysis of your ideas — don’t just sell benefits. ( this basically requires a know-how expertise which would determine understandings of ourselves about the ideas).

Rosabeth also gave 7 hints for selling ideas up to the management group. To sum up here: seeking input from different parties, be an expert in what you know, make personal contacts to sell yourself even before selling the idea, and be specific about what is going to be expected, and what you can deliver.

http://blogs.hbr.org/cs/2008/06/how_to_influence_up_and_become.htmlHere
Categories
Uncategorized

The CEO’s Innovation Nightmare

This article from Business Week highlights many of the challenges to rebuilding a business for innovation that we discussed in class.  It provides advise to a turnaround CEO… much of the points align with our conclusions from class.  Namely:

  • Recruit Believers – As with Intuit case, the change required fresh talent with innovative thinking;
  • Hire Objective Senior Managers – creating the right metrics and accountability measures is critical (as we saw in Donnelly);
  • Fail Forward – encourage risk-taking; and,
  • Control the Framing – this is an interesting idea that we did not discuss: “If you control the language, you control the expectations.”

I think these points are warranted, even if unsubstantiated with real-life examples in the article.  I liked this perspective, because it is resonates with many of the themes we have discussed in class.

The article ends with some practical advise about immovable innovation obstacles — quit!  What do you think about the idea of quitting when the going gets tough in innovation?

Categories
Uncategorized

Tata Motors disrupts with the Nano

Tata Motors is an Indian owned automotive company.  Their core business is in selling trucks in India, where they hold 61% of the market.  In recent years they have been expanding into the consumer car market.  Tata purchased Jaguar and Land Rover from Ford and has turned a profit in three consecutive quarters.  Better yet their innovation has disrupted the market with the Tata Nano, the world’s lowest-priced car.

http://seekingalpha.com/article/221696-tata-motors-puts-the-pedal-to-the-metal-in-indias-car-market